Navigation Links
IVF Thanksgiving: Reproductive Science Center Marks 25th Anniversary

Boston, MA (PRWEB) November 25, 2013

RSC New England is celebrating its 25th anniversary year. But, most importantly, November marks the birth of the first baby conceived through in vitro fertilization (IVF) facilitated by the Reproductive Science Center’s fertility expert doctors and embryologists.

Looking back at the development of reproductive science, the first IVF baby, Louise Brown, was born in England in 1978. Biologist Dr. Robert Edwards and his colleague Obstetrician/Gynecologist Dr. Patrick Steptoe combined the eggs and sperm of Louise’s parents together in laboratory culture media to allow fertilization and embryo development to ensue – the process known as in vitro fertilization (IVF).

In 1986, the American Society for Reproductive Medicine (ASRM) formed the organization that would become the Society for Assisted Reproductive Technology (SART). This marked the recognition of assisted reproduction as an important and specific practice of reproductive medicine.

RSC New England opened in October 1988, began doing IVF cycles in January 1989, and in November 1989 achieved its first live birth. A member of ASRM and SART since their inception, the Reproductive Science Center has participated in developing the guidelines followed nationally by ASRM member fertility treatment doctors and centers. RSC New England has also achieved and/or introduced numerous advances in the practice of reproductive medicine and assisted reproductive technology.

In March 1994, RSC was among the first fertility centers to offer Intracytoplasmic Sperm Injection (ICSI), a laboratory procedure that isolates and injects one sperm into an egg, resulting in a high likelihood of fertilization and embryo development. Considered one of the sentinel achievements in reproductive technology, ICSI has revolutionized the treatment of male factor infertility.

In 1996, Reproductive Science Center physicians and embryologists achieved pregnancy for a couple challenged by a previously untreatable form of male factor infertility known as azoospermia, in which the man has no sperm in his ejaculate. The RSC doctors were able to use sperm, which had previously been frozen after being surgically retrieved from the man’s testicles. Using ICSI, his testicular sperm was injected into eggs retrieved from his wife. Embryos developed, leading to a successful pregnancy and live birth of a healthy baby.

In addition to ICSI, RSC was also an early adopter of Preimplantation Genetic Diagnostic testing (PGD), and more specifically “microarray” technology that affords a much higher sensitivity for genetic mutation detection or chromosome copy number determination in embryos. RSC Science and Laboratory Director Kathryn Go, PhD explains that, “The evolution of these methods is critically important in all areas of medicine and is widely applied to understand the differences between healthy and diseased cells and tissues.”

The 1990s also marked the emergence of “third party reproduction” -- the use of egg donors and gestational surrogates. These were critical in expanding services to older infertile women especially, as well as women who could not gestate (carry a pregnancy). IVF using egg donors and gestational carriers has also revolutionized the ability for male couples to have genetically related children. The Reproductive Science Center’s Medical Director, Samuel Pang, MD, was the first Reproductive Endocrinologist in New England to facilitate IVF for a gay male couple in 1998. Dr. Pang has also pioneered “Reciprocal IVF” for female couples in which one partner provides eggs and the other carries the pregnancy. (The center maintains, a website dedicated to information about assisted reproduction options for gay, lesbian and transgender men and women.)

Most recently, RSC New England has begun using “vitrification”, a rapid freezing and advanced thawing technique that enables oocytes (eggs) to be preserved. Among other benefits, vitrification enables women with cancer to preserve their fertility. RSC has an urgent response team available specifically for cancer patients.

Vitrification also enables women who are not ready for pregnancy in their peak child-bearing years to preserve their fertility through egg freezing. Couples not ready for pregnancy can also go through IVF and preserve embryos using the rapid freezing technique.

In 2010, RSC opened MyEggBank at RSC New England, a program through which young healthy women donate their eggs to be frozen, stored in the Egg Bank and available for use by couples that can only achieve pregnancy using donor eggs. The MyEggBank network, of which RSC New England is a founding member, is the largest international frozen egg bank.

One of the largest and most experienced fertility treatment centers in the United States, the Reproductive Science Center of New England provides comprehensive diagnosis, evaluation, consultation and treatment for infertility. RSC New England has 11 locations in Massachusetts, New Hampshire and Rhode Island and is a partner member of IntegraMed Fertility, the most expansive network of infertility treatment centers and fertility specialist physicians in the nation.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Auxogyn And Reproductive Medicine Associates of New Jersey Partner To Advance in vitro fertilization Research
2. Reproductive Medicine Associates of New Jersey and Auxogyn Launch Fertility Study To Advance Goals of One Embryo, One Healthy Baby
3. New Egg Donation Program, "Ovatures," Launched By Reproductive Medicine Associates Of New Jersey
4. Reproductive Medicine Associates of New Jersey Receives ACOG Prize for Paper on SET and CCS, a Pioneering IVF Process
5. Center Of Reproductive Medicine Participates In The Thrive-IVF Research Study To Help Improve Pregnancy Success Rates And Outcomes In Women With A History Of Repeated In Vitro Fertilization (IVF) Failures
6. Garage Start-ups Now Possible in Life Sciences Industry
7. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
8. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
9. Kansas Bioscience Authority Announces FY11 Outcomes of $207 Million
10. A New Mechanism for Tau Protein Pathology in Alzheimers Disease was Presented by Oligomerix, Inc. at the Society for Neuroscience Annual Meeting
11. BioSpace Spotlights Northwests Life Science Community
Post Your Comments:
(Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
(Date:11/25/2015)... 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... and CEO of Neurocrine Biosciences, will be presenting at ... New York . .   ... approximately 5 minutes prior to the presentation to download ... presentation will be available on the website approximately one ...
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... speaking at the following conference, and invited investors to ... NY      Tuesday, December 1, 2015 at 11.00 ... NY      Tuesday, December 1, 2015 at 11.00 ... Conference, New York, NY      Tuesday, ...
Breaking Biology Technology:
(Date:11/17/2015)...  Vigilant Solutions announces today that Mr. Dick ... --> --> Mr. ... partnership at TPG Capital, one of the largest global ... in revenue.  He founded and led TPG,s Operating Group, ... from 1997 to 2013.  In his first role, he ...
(Date:11/12/2015)... 12, 2015  A golden retriever that stayed healthy ... (DMD) has provided a new lead for treating this ... Broad Institute of MIT and Harvard and the University ... Cell, pinpoints a protective gene ... disease,s effects. The Boston Children,s lab of Lou ...
(Date:11/11/2015)... 2015   MedNet Solutions , an innovative SaaS-based eClinical ... is pleased to announce that it will be a Sponsor ... event, to be held November 17-19 in Hamburg ... demonstrations of iMedNet , MedNet,s easy-to-use, proven ... has been able to deliver time and cost savings ...
Breaking Biology News(10 mins):